Noodles from GSK

GlaxoSmithkline Consumer Healthcare on Wednesday announced its entry into the noodles segment, with aims to capture 10 per cent of the estimated Rs 1,000 crore organised noodles market within a year. The company launched its noodles under the popular Horlicks brand named ‘Foodles’ that is expected to compete with market leader ‘Maggi’ from Nestle.

“The Indian noodles market is estimated to be around Rs 1,000 crore and has been growing at the rate of 25 per cent. We believe that the overall entry of Horlicks will expand the category further,” Mr Subhajit Sen, Executive Vice President (Marketing), G SK Consumer Healthcare (GSKCH) India said.

The company said the new product will further extend its Rs 1,500-crore ‘Horlicks’ brand and help in sustaining the double-digit growth that it has been registering.

The company, at present is focusing on the South India. It plans to introduce the product in the National Capital and other northern states in the next six months to one year period.